J H Kleibeuker
Overview
Explore the profile of J H Kleibeuker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
169
Citations
2472
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavlov K, Meijer C, van den Berg A, Peters F, Kruyt F, Kleibeuker J
Crit Rev Oncol Hematol
. 2014 Jun;
92(1):25-37.
PMID: 24935219
Barrett's metaplasia of the esophagus (BE) is the precursor lesion of esophageal adenocarcinoma (EAC), a deadly disease with a 5-year overall survival of less than 20%. The molecular mechanisms of...
2.
van Enckevort C, de Graaf A, Hollema H, Sluiter W, Kleibeuker J, Koornstra J
Neth J Med
. 2014 May;
72(3):139-45.
PMID: 24846927
Background: Colorectal adenoma patients are kept under surveillance because of the risk of developing metachronous neoplasia. The aim is to determine predictors of neoplasia development after polypectomy. Methods: It is...
3.
Jalving M, Heijink D, Koornstra J, Boersma-van Ek W, Zwart N, Wesseling J, et al.
Carcinogenesis
. 2014 Jan;
35(5):1092-9.
PMID: 24379239
Tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL) is being investigated as a targeted cancer therapeutic and the expression of its pro-apoptotic receptors, DR4 and DR5, increases during colorectal carcinogenesis. This study investigated the...
4.
Haanstra J, Vasen H, Sanduleanu S, Van der Wouden E, Koornstra J, Kleibeuker J, et al.
Int J Colorectal Dis
. 2013 Jul;
28(12):1643-9.
PMID: 23857598
Purpose: Despite colonoscopic surveillance, Lynch syndrome patients develop colorectal cancer (CRC). Identification of modifiable factors has the potential to improve outcome of surveillance. The aims of this study were to...
5.
Buurman D, Vande Casteele N, Sturkenboom M, Kleibeuker J, Vermeire S, van der Kleij D, et al.
Aliment Pharmacol Ther
. 2012 Dec;
37(2):282.
PMID: 23252783
No abstract available.
6.
Vande Casteele N, Buurman D, Sturkenboom M, Kleibeuker J, Vermeire S, Rispens T, et al.
Aliment Pharmacol Ther
. 2012 Aug;
36(8):765-71.
PMID: 22928581
Background: Formation of antibodies to infliximab (ATI) inversely correlates with functional drug levels and clinical outcome. Comparison of drug levels and anti-drug antibody monitoring is hampered by lack of standardisation....
7.
Heijink D, Fehrmann R, de Vries E, Koornstra J, Oosterhuis D, van der Zee A, et al.
Oncogene
. 2011 Jan;
30(17):2026-36.
PMID: 21217777
Comparing normal colorectal mucosa and adenomas focusing on deregulated pathways obtains insight into the biological processes of early colorectal carcinogenesis. Publicly available microarray expression data from 26 normal mucosa and...
8.
Nieuwenhuis M, Mathus-Vliegen E, Baeten C, Nagengast F, van der Bijl J, van Dalsen A, et al.
Br J Cancer
. 2010 Nov;
104(1):37-42.
PMID: 21063417
Background: The optimal treatment of desmoid tumours is controversial. We evaluated desmoid management in Dutch familial adenomatous polyposis (FAP) patients. Methods: Seventy-eight FAP patients with desmoids were identified from the...
9.
Fiebrich H, van den Berg G, Kema I, Links T, Kleibeuker J, van Beek A, et al.
Aliment Pharmacol Ther
. 2010 Nov;
32(11-12):1398-404.
PMID: 21050243
Background: Somatostatin analogues are administered to control hormone hypersecretion in acromegaly and carcinoid patients. Somatostatin analogues can increase fat in the stools, which can lead to loss of fat-soluble vitamins....
10.
van der Meulen-de Jong A, Morreau H, Becx M, Crobach L, van Haastert M, Ten Hove W, et al.
Gut
. 2010 Sep;
60(1):73-6.
PMID: 20833659
Background And Aims: Subjects with one first-degree relative (FDR) with colorectal cancer (CRC) <50 years old or two FDRs with CRC have an increased risk for CRC (RR 4-6). Current...